Medtronic awards stock, options to EVP Kweli

Accepted by SEC EDGAR 08/04/2026 - 07:59 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Medtronic EVP & President, Neuroscience Thompson Kweli received equity compensation awards, including 17,306 performance share units, 49,167 stock options with a strike price of $86.68 expiring in 2036, and 6,923 restricted stock units vesting after three years. Separately, 1,739 shares were withheld to satisfy taxes on previously vested RSUs.

Insider Trade Summary

4 transactions reported

Mixed 4 txns

Insider Thompson Kweli

Role EVP & President, Neuroscience

Type	Security	Shares	Price	Value
Grant/Award	Performance Share Units F4, F5, F6	17,306	$0.00	$0.00
Grant/Award	Stock Option (Right to Buy) F7	49,167	$0.00	$0.00
Grant/Award	Ordinary Shares F3	6,923	$0.00	$0.00
Tax Withholding	Ordinary Shares F1, F2	1,739	$85.39	$148K

Holdings After Transaction: Performance Share Units — 17,306 contracts (Direct); Stock Option (Right to Buy) — 49,167 contracts (Direct); Ordinary Shares — 35,390 shares (Direct)

Footnotes (7)

1. F1. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.
2. F2. Includes 188 shares acquired through dividend reinvestment since the last report filed by the reporting person.
3. F3. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
4. F4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
5. F5. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.
6. F6. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,306 shares will be issued. If maximum performance metrics are achieved, 41,534 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
7. F7. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Key Figures

Performance share units granted: 17,306 units Maximum PSU payout: 41,534 shares Stock options granted: 49,167 options +4 more

7 metrics

Performance share units granted 17,306 units PSUs granted to Thompson Kweli on 2026-08-03; payout depends on performance metrics

Maximum PSU payout 41,534 shares Maximum shares issuable if PSU performance metrics are fully achieved over the three-year period

Stock options granted 49,167 options Options on Medtronic ordinary shares granted on 2026-08-03

Option exercise price $86.68 per share Exercise price for the 49,167 stock options granted to Thompson Kweli

Option expiration date 2036-08-03 Expiration date of the stock options granted on 2026-08-03

Restricted stock units granted 6,923 shares RSUs granted on 2026-08-03, vesting 100% on the third anniversary of grant

Shares withheld for taxes 1,739 shares Ordinary shares withheld on 2026-07-31 at $85.39 per share to satisfy tax liability on RSU vesting

Key Terms

Performance Share Units, restricted stock units, dividend reinvestment, performance metrics

4 terms

Performance Share Units financial

"Each performance share unit represents a contingent right to receive one share"

Performance share units are a type of company stock award given to employees that depend on the company meeting specific goals or targets. If these goals are achieved, the employee receives shares or the value of shares; if not, they may receive little or no compensation. This aligns employees’ interests with the company's success and encourages performance that benefits investors.

restricted stock units financial

"Represents restricted stock units that vest 100% on the third anniversary of grant"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

dividend reinvestment financial

"Includes 188 shares acquired through dividend reinvestment since the last report"

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

performance metrics financial

"Number of shares will vary depending on the level of certain performance metrics achieved"

Performance metrics are concrete numbers or ratios that show how well a business, product, or investment is doing—like speed, fuel use and mileage on a car’s dashboard. They measure things investors care about, such as sales growth, profitability, cash flow, customer retention or efficiency, so readers can compare progress, spot strengths or problems, and make informed decisions about buying, holding or selling shares.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Medtronic (MDT) grant to Thompson Kweli on August 3, 2026?

Thompson Kweli received 17,306 performance share units, 49,167 stock options at $86.68 per share expiring in 2036, and 6,923 restricted stock units that vest 100% on the third anniversary of the grant date as part of his equity compensation.

How do the performance share units granted to Medtronic (MDT) EVP Thompson Kweli work?

Each performance share unit represents a contingent right to receive one Medtronic share. Over a three-year performance period ending April 27, 2029, payout can range from 0 to 41,534 shares, with 17,306 shares issued if target performance metrics are achieved.

What are the terms of Thompson Kweli’s Medtronic (MDT) stock options granted on August 3, 2026?

Kweli was granted 49,167 stock options with an exercise price of $86.68 per share, expiring on August 3, 2036. These options become exercisable at a rate of 25% per year, beginning on the first anniversary of the grant date.

Why were 1,739 Medtronic (MDT) shares disposed of on July 31, 2026 for Thompson Kweli?

The 1,739 shares were withheld at $85.39 per share to pay taxes upon the vesting of previously granted restricted stock units. After this transaction, Kweli’s reported holdings include 188 shares acquired through dividend reinvestment since his prior report.

When will Thompson Kweli’s Medtronic (MDT) restricted stock units from this grant vest?

The 6,923 restricted stock units granted to Thompson Kweli on August 3, 2026 vest 100% on the third anniversary of the grant date. Until that vesting date, the units remain unearned and are subject to Medtronic’s applicable award terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thompson Kweli

(Last) (First) (Middle)

710 MEDTRONIC PARKWAY

(Street)

MINNEAPOLIS MINNESOTA 55432

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Medtronic plc [ MDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP & President, Neuroscience

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/31/2026		F		1,739(1)	D	$85.39	28,467(2)	D
Ordinary Shares	08/03/2026		A		6,923(3)	A	$0	35,390	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Share Units	(4)	08/03/2026		A		17,306		(5)	(5)	Ordinary Shares	17,306(6)	$0	17,306	D
Stock Option (Right to Buy)	$86.68	08/03/2026		A		49,167		(7)	08/03/2036	Ordinary Shares	49,167	$0	49,167	D

Explanation of Responses:

1. Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I.

2. Includes 188 shares acquired through dividend reinvestment since the last report filed by the reporting person.

3. Represents restricted stock units that vest 100% on the third anniversary of the date of grant.

4. Each performance share unit represents a contingent right to receive one share of Medtronic common stock.

5. Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029.

6. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 17,306 shares will be issued. If maximum performance metrics are achieved, 41,534 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.

7. These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant.

Remarks:

	/s/ Patricia Walesiewicz, attorney-in-fact	08/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)